Panbela Therapeutics, Inc.
OTC: PBLA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jennifer K. Simpson
- Employees
- 7
- Headquarters
- Waconia, United States
- IPO year
- 2017
- Market cap
- $24.3K
- Website
- https://www.panbela.com
Loading PBLA…
Loading profile data…Frequently asked questions about PBLA
What does Panbela Therapeutics, Inc. (PBLA) do?
Panbela Therapeutics, Inc. is a biopharmaceutical enterprise currently in clinical development, along with its subsidiaries, dedicated to advancing innovative therapies for cancer patients. The company's therapeutic endeavors primarily target pancreatic disorders, including pancreatitis, pancreatic cancer, and neoadjuvant pancreatic cancer. Beyo...
Where does PBLA trade?
Panbela Therapeutics, Inc. (PBLA) trades on the Other OTC.
What sector is PBLA in?
Panbela Therapeutics, Inc. (PBLA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Panbela Therapeutics, Inc.?
Jennifer K. Simpson is the chief executive officer of Panbela Therapeutics, Inc. (PBLA).
Where is Panbela Therapeutics, Inc. headquartered?
Panbela Therapeutics, Inc. is headquartered in United States.
Does PBLA pay a dividend?
Panbela Therapeutics, Inc. (PBLA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PBLA go public?
Panbela Therapeutics, Inc. (PBLA) completed its initial public offering in 2017.